Singlepen A 2.0

SINGLEPEN A 2.0

  • Atropine Sulphate

First Aid Against Organophosphate and Nerve Agent Exposure - Autoinjector

SINGLEPEN A is a single-chamber semi-automatic autoinjector containing Atropine Sulfate. The device is developed for the emergency management of cholinergic symptoms resulting from organophosphate and nerve agent exposure.

During the critical pre-hospital phase, SINGLEPEN A enables rapid intramuscular administration of atropine, supporting early antidote intervention in CBRN incidents and military/tactical operational environments.

  • Atropine Sulfate 2mg / 2ml content
  • Single-chamber, semi-automatic autoinjector design
  • Rapid and controlled intramuscular injection
  • Ergonomic and robust construction suitable for military and tactical use
  • Reliable operation under stress, protective equipment, and harsh field conditions
Singlepen A 2.0 image 1

Operational Concept

  • Designed according to Individual First Aid (IFA) principles
  • Suitable for Self-Aid and Buddy-Aid applications
  • Intended for use in CBRN response and military medical support systems
  • Fully compatible with ChemProtect autoinjector deployment concepts

Intended Use

  • Organophosphate poisoning
  • Nerve agent exposure (G-series and V-series agents)
  • CBRN incidents and chemical warfare scenarios
  • Emergency pre-hospital antidote administration

User Group / Scope of Use

  • Armed Forces
  • CBRN Defense Units
  • Law Enforcement Agencies
  • Special Operations Forces and Tactical Medical Personnel

    • *Not intended for civilian use

Packaging & Logistics

  • Single-use single-chamber semi-automatic autoinjector
  • Tactical-ready configuration for field deployment
  • Packaging, shelf life, and logistics details available upon request

Contents

  • Active Ingredient: Atropine Sulfate
  • Dosage: 2mg / 2ml

Compliance & Standards

  • GMP, GDP, GLP
  • ISO 9001:2015 and ISO 13485:2016
  • Applicable NATO STANAG standards

    • (Specific certifications and STANAG references are available upon request, subject to official documentation.)